NCT06581120
GLP_1 RA Ultrasound Study
Enrolling by Invitation
Not specifiedAges 10–25ObservationalChildren's Hospital Medical Center, CincinnatiInvestigator-initiated
~100 participants
Updated 2024-11-07 on ClinicalTrials.gov
What's tested:Glucagon-Like Peptide-1 receptor agonistsPoint of Care Gastric Ultrasound
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Aspiration Risk determined by POGUS
Measured over Two years
Conditions
Where it's being run
1 sites across 1 statesOhio1
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Body Mass Index over 35
Type 2 Diabetes
Currently taking GLP01 RA agonist (for GLP 1 group)
Not taking GLP-1 RA agonist (for control group)
Exclusion
Diagnosis of gastroparesis
patient refusal to participate
Previous gastric bypass or any other gastric surgery
Currently on peritoneal dialysis
Abdominal pathology
Gastro-intestinal obstruction
Pregnancy
What this trial measures
- Aspiration Risk determined by POGUSTwo years
Difference between control group and GLP-1 group. Measured by Gastric contents during Point of Care Gastric Ultrasound.